stock-detail (JUNO)

Oncology Corporate Profile

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
JCAR015CD19 inhibitorNon-Hodgkin's Lymphoma (NHL)II
JTCR016WT-1 inhibitorAcute Myelogenous Leukemia (AML)I
JCAR023L1CAM antibodyNeuroblastomaI
JTCR016WT-1 inhibitorNon Small Cell Lung Cancer (NSCLC)I
JCAR017CD19 inhibitorNon-Hodgkin's Lymphoma (NHL)I
JCAR017CD19 inhibitorPediatric Acute Lymphocytic Leukemia (ALL)I
JCAR018CD-22 inhibitorChronic Lymphocytic Leukemia (CLL)

Recent News Headlines

8/21/2017 06:20 am

8/21/2017 06:20 am

8/21/2017 06:20 am

8/21/2017 06:20 am

8/21/2017 06:20 am

8/21/2017 12:20 am

8/21/2017 12:20 am

8/21/2017 12:20 am

8/21/2017 12:20 am

8/18/2017 06:18 pm

8/18/2017 12:19 pm

8/18/2017 12:19 pm

8/18/2017 12:19 pm

8/18/2017 12:19 pm

8/18/2017 12:19 pm

8/18/2017 06:18 am

8/17/2017 06:18 am

8/13/2017 12:18 am

8/13/2017 12:18 am

8/12/2017 12:20 pm

8/12/2017 12:20 pm

8/12/2017 12:20 pm

8/11/2017 06:18 pm

8/9/2017 12:18 pm

8/8/2017 12:18 pm